These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37495321)

  • 1. Early Rhythm Control in Patients With Incident Atrial Fibrillation Who Had a Prior Stroke.
    Lee SR; Choi EK; Lee SW; Han KD; Oh S; Lip GYH
    JACC Clin Electrophysiol; 2023 Jul; 9(7 Pt 2):1121-1133. PubMed ID: 37495321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Rhythm Control and Incident Dementia in Patients With Atrial Fibrillation and Prior Stroke.
    Lee SR; Choi EK; Lee SW; Han KD; Oh S; Lip GYH
    JACC Clin Electrophysiol; 2024 Jul; 10(7 Pt 1):1409-1420. PubMed ID: 38727665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank.
    Kany S; Cardoso VR; Bravo L; Williams JA; Schnabel R; Fabritz L; Gkoutos GV; Kirchhof P
    Heart; 2022 Nov; 108(23):1873-1880. PubMed ID: 35835543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Rhythm Control Therapy for Atrial Fibrillation in Low-Risk Patients : A Nationwide Propensity Score-Weighted Study.
    Kim D; Yang PS; You SC; Jang E; Yu HT; Kim TH; Pak HN; Lee MH; Lip GYH; Sung JH; Joung B
    Ann Intern Med; 2022 Oct; 175(10):1356-1365. PubMed ID: 36063552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study.
    Kim D; Yang PS; You SC; Sung JH; Jang E; Yu HT; Kim TH; Pak HN; Lee MH; Lip GYH; Joung B
    Age Ageing; 2022 Jan; 51(1):. PubMed ID: 35061873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks and Benefits of Early Rhythm Control in Patients With Acute Strokes and Atrial Fibrillation: A Multicenter, Prospective, Randomized Study (the RAFAS Trial).
    Park J; Shim J; Lee JM; Park JK; Heo J; Chang Y; Song TJ; Kim DH; Lee HA; Yu HT; Kim TH; Uhm JS; Kim YD; Nam HS; Joung B; Lee MH; Heo JH; Pak HN;
    J Am Heart Assoc; 2022 Feb; 11(3):e023391. PubMed ID: 35043663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early Rhythm Control and the Risks of Ischemic Stroke, Heart Failure, Mortality, and Adverse Events When Performed Early (<3 Months): A Nationwide Cohort Study of Newly Diagnosed Patients with Atrial Fibrillation.
    Chao TF; Chan YH; Chiang CE; Tuan TC; Liao JN; Chen TJ; Lip GYH; Chen SA
    Thromb Haemost; 2022 Nov; 122(11):1899-1910. PubMed ID: 35322396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
    JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.
    Kirchhof P; Camm AJ; Goette A; Brandes A; Eckardt L; Elvan A; Fetsch T; van Gelder IC; Haase D; Haegeli LM; Hamann F; Heidbüchel H; Hindricks G; Kautzner J; Kuck KH; Mont L; Ng GA; Rekosz J; Schoen N; Schotten U; Suling A; Taggeselle J; Themistoclakis S; Vettorazzi E; Vardas P; Wegscheider K; Willems S; Crijns HJGM; Breithardt G;
    N Engl J Med; 2020 Oct; 383(14):1305-1316. PubMed ID: 32865375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of timing in treatment of atrial fibrillation: An AFFIRM substudy.
    Yang E; Tang O; Metkus T; Berger RD; Spragg DD; Calkins HG; Marine JE
    Heart Rhythm; 2021 May; 18(5):674-681. PubMed ID: 33383228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalizability of the EAST-AFNET 4 Trial: Assessing Outcomes of Early Rhythm-Control Therapy in Patients With Atrial Fibrillation.
    Dickow J; Kirchhof P; Van Houten HK; Sangaralingham LR; Dinshaw LHW; Friedman PA; Packer DL; Noseworthy PA; Yao X
    J Am Heart Assoc; 2022 Jun; 11(11):e024214. PubMed ID: 35621202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-year impact of catheter ablation for atrial fibrillation in patients with a prior history of stroke.
    Bunch TJ; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Jacobs V; Mallender C; Osborn JS; Weiss JP
    J Cardiovasc Electrophysiol; 2018 Feb; 29(2):221-226. PubMed ID: 29131434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial.
    Kany S; Al-Taie C; Roselli C; Pirruccello JP; Borof K; Reinbold C; Suling A; Krause L; Reissmann B; Schnabel RB; Zeller T; Zapf A; Wegscheider K; Fabritz L; Ellinor PT; Kirchhof P
    Cardiovasc Res; 2023 Aug; 119(9):1799-1810. PubMed ID: 37264683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risks and benefits of rate control versus maintenance of sinus rhythm.
    Saxonhouse SJ; Curtis AB
    Am J Cardiol; 2003 Mar; 91(6A):27D-32D. PubMed ID: 12670639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic management of atrial fibrillation: established and emerging options.
    Kalus JS
    J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-World Comparison of Classes IC and III Antiarrhythmic Drugs as an Initial Rhythm Control Strategy in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    Kipp R; Askari M; Fan J; Field ME; Turakhia MP
    JACC Clin Electrophysiol; 2019 Feb; 5(2):231-241. PubMed ID: 30784696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stroke and Cardiovascular Events After Ablation or Antiarrhythmic Drugs for Treatment of Patients With Atrial Fibrillation.
    Mansour M; Heist EK; Agarwal R; Bunch TJ; Karst E; Ruskin JN; Mahapatra S
    Am J Cardiol; 2018 May; 121(10):1192-1199. PubMed ID: 29571722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of Early Rhythm Control Versus Rate Control for Cardiovascular Outcomes in Patients With Atrial Fibrillation.
    Kim D; Yang PS; You SC; Jang E; Yu HT; Kim TH; Pak HN; Lee MH; Lip GYH; Sung JH; Joung B
    J Am Heart Assoc; 2021 Dec; 10(24):e023055. PubMed ID: 34889116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.